News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Miller-Rich Nancy
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/05/2023 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 21,222 options to buy
@ $8.39, valued at
$178.1k
Granted 915 options to buy
@ $8.39, valued at
$7.7k
|
|
| 05/25/2023 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 8,111 shares
@ $0
Granted 12,547 options to buy
@ $9.17, valued at
$115.1k
|
|
| 05/25/2023 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $17.98, valued at
$404.6k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on 4D Molecular Therapeutics, Inc.|
Txns:
| Granted 22,500 options to buy
@ $7.77, valued at
$174.8k
|
|
| 11/09/2021 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Disposed/sold 36,364 options to buy
@ $4.17, valued at
$151.6k
Disposed/sold 96,975 options to buy
@ $3.58, valued at
$347.2k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on 4D Molecular Therapeutics Inc.|
Txns:
| Granted 22,500 options to buy
@ $26.89, valued at
$605k
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2020 |
3
| Miller-Rich Nancy (Director) has filed a Form 3 on 4D Molecular Therapeutics Inc. |
| 08/13/2020 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 36,364 options to buy
@ $4.17, valued at
$151.6k
|
|
| 08/13/2020 |
3
| Miller-Rich Nancy (Director) has filed a Form 3 on Kadmon Holdings, Inc. |
| 06/11/2020 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 26,503 options to buy
@ $5.02, valued at
$133k
|
|
| 06/01/2020 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,595 shares
@ $0
Granted 2,966 options to buy
@ $72.74, valued at
$215.7k
|
|
| 01/15/2020 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on Aldeyra Therapeutics, Inc.|
Txns:
| Granted 24,264 options to buy
@ $6.15, valued at
$149.2k
|
|
| 01/15/2020 |
3
| Miller-Rich Nancy (Director) has filed a Form 3 on Aldeyra Therapeutics, Inc. |
| 06/21/2019 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 1,570 shares
@ $0
Granted 2,174 options to buy
@ $82.25, valued at
$178.8k
|
|
| 06/22/2018 |
4
| Miller-Rich Nancy (Director) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 4,373 shares
@ $0
Granted 7,684 options to buy
@ $85.12, valued at
$654.1k
|
|
| 04/25/2018 |
3
| Miller-Rich Nancy (Director) has filed a Form 3 on INTERCEPT PHARMACEUTICALS, INC. |
|
|